Treatment of advanced Parkinson's disease by subthalamotomy: One-year results

Movement Disorders

Volumn 18, Issue 5, 2003, Pages 531-538

  Su, Philip C ^a   Tseng, Ham Min ^a   Liu, Hon Man ^a   Yen, Ruoh Fang ^a   Liou, Horng Huei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hemiballism; Micro electrode; Parkinson's disease; Subthalamic nucleus; Subthalamotomy; Surgical ablative therapy

Indexed keywords

BROMOCRIPTINE; LEVODOPA; PERGOLIDE;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; BODY POSTURE; BRADYKINESIA; BRAIN MAPPING; BRAIN SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSKINESIA; FEMALE; GAIT; GAIT DISORDER; HEMATOMA; HEMIBALLISM; HUMAN; MALE; MORTALITY; MOTOR PERFORMANCE; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SUBTHALAMIC NUCLEUS; SUBTHALAMOTOMY; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; THERMOCOAGULATION; TREATMENT OUTCOME; TREMOR;

ADULT; AGED; ANTIPARKINSON AGENTS; DYSKINESIAS; ELECTROCOAGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOKINESIA; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MICROELECTRODES; MIDDLE AGED; PARKINSON DISEASE; POSTOPERATIVE COMPLICATIONS; POSTURE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; TIME;

EID: 0037809608     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10393     Document Type: Article

References (35)

1. Parkinson Study group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 1996;39:37-45.
2. Laitinen LV, Bergenheim T. Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
3. Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-366.
4. Lai EC, Jankovic J, Krauss JK, Ondo WG, Grossman RG. Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease. Neurology 2000;55:1218-1222.
5. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medical pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.
6. Obeso JA, Rodriguez MC, DeLong MR. The basal ganglia pathophysiology: a critical review. Adv Neurol 1997;74:3-18.
7. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, prefrontal and limbic functions. Prog Brain Res 1990;85:119-146.
8. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6:751-758.
9. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia- thalamo-cortical loop. Brain Res Brain Res Rev 1995;20:91-127.
10. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249:1436-1438.
11. Guridi J, Herrero MT, Luquin MR, Guillen J, Ruberg M, Laguna J, Vila M, Javoy-Agid F, Agid Y, Hirsch E, Obeso JA. Subthalamotomy in parkinsonian monkeys. Behav Biochem Analysis. Brain 1996;119:1717-1727.
12. Levy R, Lang AE, Dostrovsky JO, et al. Lidocaine and muscimol microinjections in subthalamic nucleus reverse parkinsonian symptoms. Brain 2001;124:2105-2118.
13. Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 1993;5:382-389.
14. Guridi J, Herrero MT, Luquin MR, Obeso JA. The subthalamic nucleus: a new possible stereotaxic target for Parkinson's disease. Mov Disord 1993;8:421-429.
15. Aziz TZ, Peggs D, Agarwal E, Sambrook MA, Crossman AR. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. Br J Neurosurg 1992;6:575-582.
16. Krause M, Fogel W, Heck A, Hacke W, Bonsanto M, Trenkwalder C, Tronnier V. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry. 2001;70:464-470.
17. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999;53:85-90.
18. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339: 1105-1111.
19. Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Ghilardi MF, Yen RF, Liu HM, Moeller JR, Eidelberg D. Metabolic changes following subthalamotomy for advanced Parkinson's disease. Ann Neurol 2001;50:514-520.
20. Gill SS, Heywood P. Bilateral subthalamic nucleotomy can be accomplished safely [abstract]. Mov Disord 1998;(Suppl. 2):266.
21. Alvarez L, Macias R, Guridi J, et al. Unilateral dorsal subthalamotomy for Parkinson's disease (PD) [abstract]. Mov Disord 1998; (Suppl. 2):266.
22. Alvarez L, Macias R, Guridi J, et al. Dorsal subthalamotomy for Parkinson's disease. Mov Disord 2001;16:72-78.
23. Su PC, Tseng HM, Liu HM, et al. Unilateral subthalamotomy in the treatment of advanced Parkinson's disease [abstract]. Mov Disord 2000(Suppl. 3):334
24. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
25. Fahn S, Elton R, members of the UPDRS development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M. editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987. p 153-164.
26. Zonenshayn M, Rezai AR, Mogilner AY, Beric A, Sterio D, Kelly PJ. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery 2000;47:282-292.
27. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiologic identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628.
28. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. Stuttgart: Georg Thieme Publishers; 1977.
29. Kazumata K, Antonini A, Dhawan V, et al. Preoperative indicators of clinical outcome following stereotaxic pallidotomy. Neurology 1997;49:1083-1090.
30. Su PC, Tseng HM, Liou HH: Postural asymmetries following unilateral subthalamotomy for advanced Parkinson's disease. Mov Disord (in press).
31. The deep-brain stimulation for Parkinson's disease study group: deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
32. Kumar R, Lozano AM, Sime E, Halket E, Lang AE. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 1999;53:561-566.
33. Guridi J, Obeso JA. The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. Brain 2001;124:5-19.
34. Carpenter MB, Whittier JR, Mettler FA. Analysis of choreoid hyperkinesia in the rhesus monkey. Surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus of Luys. J Comp Neurol 1950;92:293-331.
35. Lozano AM. The subthalamic nucleus: myth and opportunities. Mov Disord 2001;16:183-184.